首页> 外文期刊>The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation >Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
【24h】

Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.

机译:早期结合N末端脑钠肽和心脏肌钙蛋白T联合测量对失代偿性心力衰竭患者的长期危险分层的重要性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Markers of myocardial necrosis and natriuretic peptides are risk predictors in decompensated heart failure (DHF). We prospectively studied the optimal timing of combined cardiac troponin T (cTnT) and N-terminal pro-brain natriuretic peptide (NT-proBNP) measurements for long-term risk stratification. METHODS: cTnT and NT-proBNP were measured upon admission, and before discharge in 76 patients hospitalized for DHF (mean age 62.3 +/- 15 years; 71% men). RESULTS: During a mean follow-up of 252 +/- 120 days, 39.5% of patients died or were re-hospitalized for DHF. From receiver-operator-characteristic (ROC) curves, the selected cut-off values for cTnT and NT-proBNP were 0.026 ng/ml and 3,700 pg/ml on admission, and 0.030 ng/ml and 3,200 pg/ml, respectively, at discharge. Depending upon measurements above vs below cut-off, the population was distributed on admission and before discharge for three groups: both negative (24% and 30% of patients); one positive (43% and 42%); and both positive (33% and 28%). For the admission groups, the 1-year DHF-free re-hospitalization survival rates were 85%, 60% and 34%, respectively (p = 0.0047). One-year survival rates for DHF-free re-hospitalization were 63%, 71% and 26% (p = 0.0029), respectively, for the discharge groups. In the Cox proportional hazards model, systolic blood pressure (hazard ratio [HR]: 0.98; 95% confidence interval [CI]: 0.96 to 0.99), heart rate (HR: 0.97; 95% CI: 0.94 to 0.98), one positive biomarker on admission (HR: 10.5; 95% CI: 1.3 to 83.7) and two positive biomarkers on admission (HR: 13.9; 95% CI: 1.8 to 98.5) were independent predictors of long-term outcomes. However, NT-proBNP on admission was the most important predictor of long-term prognosis (HR: 5.1; 95% CI: 2.3 to 12.2). CONCLUSIONS: The combined measurements of cTnT and NT-proBNP on hospital admission were more reliable than their measurements before discharge in the long-term risk stratification of DHF. A single positive measurement on admission predicted a poor long-term outcome.
机译:背景:心肌坏死和利钠肽的标记是失代偿性心力衰竭(DHF)的风险预测指标。我们前瞻性地研究了将心肌肌钙蛋白T(cTnT)和N端脑钠肽前体(NT-proBNP)联合测量的最佳时机,以进行长期风险分层。方法:入院时和出院前对76例因DHF住院的患者(平均年龄62.3 +/- 15岁; 71%的男性)进行了cTnT和NT-proBNP的测量。结果:在平均252 +/- 120天的随访期间,有39.5%的患者因DHF死亡或再次住院。根据接收者-操作者特征(ROC)曲线,入院时cTnT和NT-proBNP的选择截止值为0.026 ng / ml和3,700 pg / ml,在入库时分别为0.030 ng / ml和3200 pg / ml。卸货。根据高于或低于临界值的测量结果,将人群分为三组:入院时和出院前:阴性(分别占患者的24%和30%);一名正面(43%和42%);均为正数(分别为33%和28%)。对于入院组,无DHF的1年无院再住院生存率分别为85%,60%和34%(p = 0.0047)。出院组无DHF的再次住院治疗的一年生存率分别为63%,71%和26%(p = 0.0029)。在Cox比例风险模型中,收缩压(风险比[HR]:0.98; 95%置信区间[CI]:0.96至0.99),心率(HR:0.97; 95%CI:0.94至0.98),一项为阳性入院时的生物标志物(HR:10.5; 95%CI:1.3至83.7)和入院时的两个阳性生物标志物(HR:13.9; 95%CI:1.8至98.5)是长期预后的独立预测因子。然而,入院时NT-proBNP是长期预后的最重要预测指标(HR:5.1; 95%CI:2.3至12.2)。结论:在DHF的长期风险分层中,入院时cTnT和NT-proBNP的联合测量比出院前的测量更可靠。入院时单项阳性测量预示长期预后不良。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号